Pancreatic Cancer Research

ResearcherUniversity of Colorado DenverNo recent work listed

Christopher J. Moody

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0487-041X; OpenAlex author ID A5064587381. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Phenoxy- and Phenylamino-Heterocyclic Quinones: Synthesis and Preliminary Anti-Pancreatic Cancer Activity. Co-author DOI 10.1002/cbdv.202101036↗
  2. Antitumour indolequinones: synthesis and activity against human pancreatic cancer cells. Last author DOI 10.1039/c4ob00711e↗
  3. Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling. Co-author DOI 10.1124/mol.111.076091↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martyn W. Inman · 2 shared papers, 2014–2022 · strength 0.19
  2. Patricio Sánchez · 1 shared paper, 2022 · strength 0.14
  3. Cristian O. Salas · 1 shared paper, 2022 · strength 0.14
  4. Ricardo A. Tapia · 1 shared paper, 2022 · strength 0.14
  5. David M. Siegel · 2 shared papers, 2012–2014 · strength 0.09
  6. Chao Yan · 2 shared papers, 2012–2014 · strength 0.09
  7. David Ross · 2 shared papers, 2012–2014 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.